Differential expression of toll-like receptor 2 on dendritic cells from asymptomatic and symptomatic atopic donors

International Archives of Allergy and Immunology

Volumn 159, Issue 1, 2012, Pages 41-50

  Von Bubnoff, D ^a   Sell, U ^a   Arriens, S ^a   Specht, S ^a   Hoerauf, A ^a   Bieber, T ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Asymptomatic atopy; Dendritic cells; Toll like receptor 2

Indexed keywords

IMMUNOGLOBULIN E; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ADULT; ARTICLE; ASYMPTOMATIC ATOPY; ATOPY; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PSORIASIS; REAL TIME POLYMERASE CHAIN REACTION; SYMPTOMATIC ATOPY;

ADOLESCENT; ADULT; ALLERGENS; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; MONOCYTES; PSORIASIS; RNA, MESSENGER; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; YOUNG ADULT;

EID: 84860568901     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000335234     Document Type: Article

References (36)

1. Bousquet J, Anto JM, Bachert C, Bousquet PJ, Colombo P, Crameri R, Daeron M, Fokkens W, Leynaert B, Lahoz C, Maurer M, Passalacqua G, Valenta R, van Hage M, Van Ree R: Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA 2 LEN project. Allergy 2006; 61: 671-680. (Pubitemid 43801400)
2. von Bubnoff D, Fimmers R, Bogdanow M, Matz H, Koch S, Bieber T: Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure. Clin Exp Allergy 2004; 34: 1056-1063. (Pubitemid 38969541)
3. von Bubnoff D, Scheler M, Hinz T, Matz H, Koch S, Bieber T: Comparative immunophenotyping of monocytes from symptomatic and asymptomatic atopic individuals. Allergy 2004; 59: 933-939. (Pubitemid 39141404)
4. Wollenberg A, Bieber T: Atopic dermatitis: from the genes to skin lesions. Allergy 2000; 55: 205-213. (Pubitemid 30146114)
5. Hinz D, Simon JC, Maier-Simon C, Milkova L, Roder S, Sack U, Borte M, Lehmann I, Herberth G: Reduced maternal regulatory T cell numbers and increased T helper type 2 cytokine production are associated with elevated levels of immunoglobulin E in cord blood. Clin Exp Allergy 2010; 40: 419-426.
6. Ozdemir C, Akdis M, Akdis CA: T-cell response to allergens. Chem Immunol Allergy 2010; 95: 22-44.
7. Opitz B, van Laak V, Eitel J, Suttorp N: Innate immune recognition in infectious and noninfectious diseases of the lung. Am J Respir Crit Care Med 2010; 181: 1294-1309.
8. Darsow U, Wollenberg A, Simon D, Taieb A, Werfel T, Oranje A, Gelmetti C, Svensson A, Deleuran M, Calza AM, Giusti F, Lubbe J, Seidenari S, Ring J: ETFAD/EADV Eczema Task Force 2009 Position Paper on Diagnosis and Treatment of Atopic Dermatitis. J Eur Acad Dermatol Venereol 2010; 24: 317-328.
9. Bieber T: Atopic dermatitis. N Engl J Med 2008; 358: 1483-1494.
10. van den Biggelaar AH, van Ree R, Rodrigues LC, Lell B, Deelder AM, Kremsner PG, Yazdanbakhsh M: Decreased atopy in children infected with Schistosoma haematobium : a role for parasite-induced interleukin-10. Lancet 2000; 356: 1723-1727.
11. Zhang G, Rowe J, Kusel M, Bosco A, Mc-Kenna K, de Klerk N, Sly PD, Holt PG: Interleukin-10/interleukin-5 responses at birth predict risk for respiratory infections in children with atopic family history. Am J Respir Crit Care Med 2009; 179: 205-211.
12. Suzuki K, Maruya M, Kawamoto S, Sitnik K, Kitamura H, Agace WW, Fagarasan S: The sensing of environmental stimuli by follicular dendritic cells promotes immunoglobulin A generation in the gut. Immunity 2010; 33: 71-83.
13. Grammatikos AP: The genetic and environmental basis of atopic diseases. Ann Med 2008; 40: 482-495.
14. Majak P, Brzozowska A, Bobrowska-Korzeniowska M, Stelmach I: Early exposure to unhygienic conditions and infections is associated with expression of different Tolllike receptors. J Investig Allergol Clin Immunol 2009; 19: 260-265.
15. Schaub B, Campo M, He H, Perkins D, Gillman MW, Gold DR, Weiss S, Lieberman E, Finn PW: Neonatal immune responses to TLR2 stimulation: influence of maternal atopy on FOXP3 and IL-10 expression. Respir Res 2006; 7: 40.
16. Niebuhr M, Langnickel J, Sigel S, Werfel T: Dysregulation of CD36 upon TLR-2 stimulation in monocytes from patients with atopic dermatitis and the TLR2 r753q polymorphism. Exp Dermatol 2010; 19:e296-e298.
17. Mandron M, Aries MF, Boralevi F, Martin H, Charveron M, Taieb A, Davrinche C: Agerelated differences in sensitivity of peripheral blood monocytes to lipopolysaccharide and Staphylococcus aureus toxin B in atopic dermatitis. J Invest Dermatol 2008; 128: 882-889. (Pubitemid 351374304)
18. Melvin TA, Lane AP, Nguyen MT, Lin SY: Allergic rhinitis patients with recurrent acute sinusitis have increased sinonasal epithelial cell TLR9 expression. Otolaryngol Head Neck Surg 2010; 142: 659-664.
19. Gupta GK, Agrawal DK: Cpg oligodeoxynucleotides as TLR9 agonists: therapeutic application in allergy and asthma. BioDrugs 2010; 24: 225-235.
20. Bhattacharjee RN, Akira S: Modifying Tolllike receptor 9 signaling for therapeutic use. Mini Rev Med Chem 2006; 6: 287-291.
21. Harry RA, Anderson AE, Isaacs JD, Hilkens CM: Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis. Ann Rheum Dis 2010; 69: 2042-2050.
22. Durando P, Bassetti M, Orengo G, Crimi P, Battistini A, Tiberio G, Bellina D, Talamini A, Dodi F, Ansaldi F, Alicino C, Iudici R, Sticchi L, De Florentiis D, Viscoli C, Icardi G: Hospital-acquired infections and leading pathogens detected in a regional university adult acute-care hospital in Genoa, Liguria, Italy: results from a prevalence study. J Prev Med Hyg 2010; 51: 80-86.
23. Muller AJ, Sharma MD, Chandler PR, Duhadaway JB, Everhart ME, Johnson BA, 3rd, Kahler DJ, Pihkala J, Soler AP, Munn DH, Prendergast GC, Mellor AL: Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase. Proc Natl Acad Sci USA 2008; 105: 17073-17078.
24. Li Y, Chang M, Abar O, Garcia V, Rowland C, Catanese J, Ross D, Broder S, Shiffman M, Cheung R, Wright T, Friedman SL, Sninsky J: Multiple variants in Toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection. J Hepatol 2009; 51: 750-757.
25. Morar N, Cookson WO, Harper JI, Moffatt MF: Filaggrin mutations in children with severe atopic dermatitis. J Invest Dermatol 2007; 127: 1667-1672. (Pubitemid 46933399)
26. Kerkhof M, Schouten JP, De Monchy JG: The association of sensitization to inhalant allergens with allergy symptoms: the influence of bronchial hyperresponsiveness and blood eosinophil count. Clin Exp Allergy 2000; 30: 1387-1394.
27. Salo PM, Calatroni A, Gergen PJ, Hoppin JA, Sever ML, Jaramillo R, Arbes SJ Jr, Zeldin DC: Allergy-related outcomes in relation to serum IgE: results from the National Health and Nutrition Examination Survey 2005-2006. J Allergy Clin Immunol 2011; 127: 1226-1235, e1227.
28. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, Godowski PJ: Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 1998; 395: 284-288. (Pubitemid 28447554)
29. Volz T, Nega M, Buschmann J, Kaesler S, Guenova E, Peschel A, Rocken M, Gotz F, Biedermann T: Natural Staphylococcus aureus -derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals. FASEB J 2010; 24: 4089-4102.
30. Redecke V, Hacker H, Datta SK, Fermin A, Pitha PM, Broide DH, Raz E: Cutting edge: activation of Toll-like receptor 2 induces a TH2 immune response and promotes experimental asthma. J Immunol 2004; 172: 2739-2743. (Pubitemid 38263655)
31. Patel M, Xu D, Kewin P, Choo-Kang B, Mc-Sharry C, Thomson NC, Liew FY: TLR2 agonist ameliorates established allergic airway inflammation by promoting TH1 response and not via regulatory T cells. J Immunol 2005; 174: 7558-7563. (Pubitemid 40806259)
32. von Scheele I, Larsson K, Palmberg L: Budesonide enhances Toll-like receptor 2 expression in activated bronchial epithelial cells. Inhal Toxicol 2010; 22: 493-499.
33. Aumeunier A, Grela F, Ramadan A, Pham Van L, Bardel E, Gomez Alcala A, Jeannin P, Akira S, Bach JF, Thieblemont N: Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice. PLoS One 2010; 5:e11484.
34. Prefontaine D, Banville-Langelier AA, Fiset PO, Guay J, An J, Mazer M, Hamid Q, Mazer BD: Children with atopic histories exhibit impaired lipopolysaccharide-induced Tolllike receptor-4 signalling in peripheral monocytes. Clin Exp Allergy 2010; 40: 1648-1657.
35. Novak N, Bieber T, Peng WM: The immunoglobulin E-Toll-like receptor network. Int Arch Allergy Immunol 2010; 151: 1-7.
36. Horlock C, Shakib F, Jones NS, Sewell HF, Ghaemmaghami AM: Differential protein expression by dendritic cells from atopic and non-atopic individuals after stimulation by the major house dust mite allergen Der p 1. Int Arch Allergy Immunol 2009; 150: 237-251.